OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Engineered small extracellular vesicles loaded with miR-654-5p promote ferroptosis by targeting HSPB1 to alleviate sorafenib resistance in hepatocellular carcinoma
Jiao Sun, Qi Liu, Yanfang Jiang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Jiao Sun, Qi Liu, Yanfang Jiang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 19
Showing 19 citing articles:
crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer
Yutian Zou, Anli Yang, Bo Chen, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101126-101126
Closed Access | Times Cited: 23
Yutian Zou, Anli Yang, Bo Chen, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101126-101126
Closed Access | Times Cited: 23
Epigenetic modification of ferroptosis by non-coding RNAs in cancer drug resistance
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Hongquan Wang, Joshua S. Fleishman, Sihang Cheng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Extracellular vesicle-mediated ferroptosis, pyroptosis, and necroptosis: potential clinical applications in cancer therapy
Yi-Chi Yang, Qian Jiang, Ke-Ping Yang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 13
Yi-Chi Yang, Qian Jiang, Ke-Ping Yang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 13
Targeting ferroptosis: the role of non-coding RNAs in hepatocellular carcinoma progression and therapy
Weijia Wang, Behishta Hashimi, Ping Wang
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1
Weijia Wang, Behishta Hashimi, Ping Wang
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access | Times Cited: 1
From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma
Zijian Wang, Chunyang Zhou, Yiming Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116074-116074
Open Access | Times Cited: 22
Zijian Wang, Chunyang Zhou, Yiming Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116074-116074
Open Access | Times Cited: 22
Unveiling the role of ferroptosis-associated exosomal non-coding RNAs in cancer pathogenesis
Yiping Zhang, Jun Xie
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116235-116235
Open Access | Times Cited: 5
Yiping Zhang, Jun Xie
Biomedicine & Pharmacotherapy (2024) Vol. 172, pp. 116235-116235
Open Access | Times Cited: 5
MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities
Khadijeh Mahboobnia, Dianne J. Beveridge, George C. Yeoh, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9393-9393
Open Access | Times Cited: 5
Khadijeh Mahboobnia, Dianne J. Beveridge, George C. Yeoh, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9393-9393
Open Access | Times Cited: 5
Targeting cell death mechanisms: the potential of autophagy and ferroptosis in hepatocellular carcinoma therapy
Beibei Liu, Ling Liu, Yang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Beibei Liu, Ling Liu, Yang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
sEV-mediated intercellular transformation from MGAT4AHigh to MGAT4ALow tumor cells via the HOTAIRM1/miR-196b-5p axis promotes apoptosis resistance in CTCL
Jiachen Sun, Tingting Li, Jing Cui, et al.
Oncogene (2025)
Open Access
Jiachen Sun, Tingting Li, Jing Cui, et al.
Oncogene (2025)
Open Access
Epigenetic and Post-Translational Modifications in Ferroptosis Regulation and Hepatocellular Carcinoma: New Frontiers in Therapeutic Targeting
Soheil Bolandi, Samaneh Dodge, Zahra Zahed, et al.
Pathology - Research and Practice (2025), pp. 155991-155991
Closed Access
Soheil Bolandi, Samaneh Dodge, Zahra Zahed, et al.
Pathology - Research and Practice (2025), pp. 155991-155991
Closed Access
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response
Clara Vianello, Elisa Monti, Ilaria Leoni, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 766-766
Open Access | Times Cited: 2
Clara Vianello, Elisa Monti, Ilaria Leoni, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 766-766
Open Access | Times Cited: 2
Engineered small extracellular vesicle-mediated ferroptosis: A new frontier in cancer immunotherapy
Xiao-Qi He, Y Wu
International Immunopharmacology (2024) Vol. 139, pp. 112621-112621
Closed Access | Times Cited: 2
Xiao-Qi He, Y Wu
International Immunopharmacology (2024) Vol. 139, pp. 112621-112621
Closed Access | Times Cited: 2
Non-coding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response
Clara Vianello, Elisa Monti, Ilaria Leoni, et al.
(2024)
Open Access | Times Cited: 1
Clara Vianello, Elisa Monti, Ilaria Leoni, et al.
(2024)
Open Access | Times Cited: 1
Exploiting cell death and tumor immunity in cancer therapy: challenges and future directions
Jiaan Lu, Ru He, Yang Liu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Jiaan Lu, Ru He, Yang Liu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Regulating ferroptosis by non-coding RNAs in hepatocellular carcinoma
Lijie Sun, Hongfei Cao, Yanzhe Wang, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Lijie Sun, Hongfei Cao, Yanzhe Wang, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Extracellular Vesicles in the HCC Microenvironment: Implications for Therapy and Biomarkers
Le Cheng, Limin Zhang, Xiaoxiao Wang, et al.
Pharmacological Research (2024), pp. 107419-107419
Open Access | Times Cited: 1
Le Cheng, Limin Zhang, Xiaoxiao Wang, et al.
Pharmacological Research (2024), pp. 107419-107419
Open Access | Times Cited: 1
A polo-like kinase 1 inhibitor enhances erastin sensitivity in head and neck squamous cell carcinoma cells in vitro
Xiangping Wu, Jing Wu
Cancer Chemotherapy and Pharmacology (2024) Vol. 94, Iss. 2, pp. 183-195
Open Access
Xiangping Wu, Jing Wu
Cancer Chemotherapy and Pharmacology (2024) Vol. 94, Iss. 2, pp. 183-195
Open Access
Advances in hepatocellular carcinoma drug resistance models
Yien Xiang, Junhua Wu, Hanjiao Qin
Frontiers in Medicine (2024) Vol. 11
Open Access
Yien Xiang, Junhua Wu, Hanjiao Qin
Frontiers in Medicine (2024) Vol. 11
Open Access
MicroRNA-mediated regulation of Ferroptosis: Implications for disease pathogenesis and therapeutic interventions
Shokufeh Razi, Javad Yaghmoorian Khojini, Hamid Norioun, et al.
Cellular Signalling (2024) Vol. 125, pp. 111503-111503
Closed Access
Shokufeh Razi, Javad Yaghmoorian Khojini, Hamid Norioun, et al.
Cellular Signalling (2024) Vol. 125, pp. 111503-111503
Closed Access
Emerging insights into the role of microRNAs regulation of ferroptosis in hepatocellular carcinoma
Qi Zhang, Yingdan Zhang, Shiyun Guo, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 3, pp. 167642-167642
Closed Access
Qi Zhang, Yingdan Zhang, Shiyun Guo, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 3, pp. 167642-167642
Closed Access
